Innovation Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IPIX Innovation Pharmaceuticals Inc
LOTE Lot78 Inc
GIXEF Geologix Explorations Inc
GILXF Gitennes Exploration Inc
GIKLY Grifols SA
GIGNY Genting Singapore Ltd
GIGNF Genting Singapore Ltd
GIDYL GI Dynamics Inc
GHST Ghst International Inc
GHRI Goliath Resources Inc
Go

Health Care : Biotechnology | Company profile

Innovation Pharmaceuticals Inc., formerly Cellceutix Corporation, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies with oncology, dermatology and antimicrobial applications. The Company owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics. The Company's clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Prurisol for the treatment of psoriasis, and Brilacidin for treatments of skin infections, prevention of oral mucositis complicating chemoradiation treatment for cancer, and ulcerative proctitis. The Company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics and inflammatory disease.

Closing Price
$0.36
Day's Change
0.02 (5.88%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.36
Day's Low
0.325
Volume
(Heavy Day)
Volume:
315,313

10-day average volume:
201,985
315,313

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.